Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
27,21 EUR | +0,11% | +1,15% | -3,06% |
Attività
- trattamento dialitico (46,9%; Fresenius Medical Care): vendita di apparecchiature per emodialisi, dialisi pediatrica, dialisi peritoneale, servizi di dialisi, ecc;
- amministrazione ospedaliera e ingegneria (34,1%; Fresenius Vamed e Fresenius Helios): gestione di strutture tecniche e attrezzature mediche, gestione ospedaliera, progettazione e produzione di attrezzature mediche per il settore farmaceutico, ecc;
- perfusione e nutrizione clinica (19%; Fresenius Kabi): vendita di prodotti per la nutrizione parenterale e orale, apparecchiature per la perfusione e il riempimento vascolare, materiali trasfusionali, prodotti iniettabili generici, servizi di assistenza medica a domicilio nelle aree della perfusione, della nutrizione e dell'ossigenoterapia, ecc.
Le vendite nette sono distribuite geograficamente come segue: Europa (43,8%), Nord America (39,4%), Asia/Pacifico (10,1%), America Latina (5,4%) e Africa (1,3%).
Numero di dipendenti: 193 865
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Fresenius Helios
55,1
%
| 11 690 | 28,6 % | 12 295 | 55,1 % | +5,18% |
Fresenius Kabi
35,7
%
| 7 779 | 19,0 % | 7 961 | 35,7 % | +2,34% |
Fresenius Vamed
9,2
%
| 2 039 | 5,0 % | 2 043 | 9,2 % | +0,20% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Germany
38,6
%
| 8 766 | 21,5 % | 8 607 | 38,6 % | -1,81% |
Spain
20,0
%
| - | - | 4 461 | 20,0 % | - |
Europe
13,8
%
| 9 111 | 22,3 % | 3 081 | 13,8 % | -66,18% |
North America
12,3
%
| 340 | 0,8 % | 2 737 | 12,3 % | +705,00% |
Asia Pacific
7,4
%
| 4 141 | 10,1 % | 1 639 | 7,4 % | -60,42% |
Latin America
6,4
%
| 2 182 | 5,3 % | 1 418 | 6,4 % | -35,01% |
Africa
1,6
%
| 534 | 1,3 % | 356 | 1,6 % | -33,33% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12/04/21 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01/01/19 |
Michael Moser
CMP | Compliance Officer | - | 18/07/23 |
Public Communications Contact | - | - | |
Markus Georgi
IRC | Investor Relations Contact | - | 01/01/15 |
Corporate Officer/Principal | - | 01/10/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20/05/15 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01/01/20 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 16/07/07 |
Michael Albrecht
BRD | Director/Board Member | 74 | 28/01/11 |
Susanne Zeidler
BRD | Director/Board Member | 63 | 09/02/22 |
Director/Board Member | 50 | 01/01/08 | |
Frauke Lehmann
BRD | Director/Board Member | 60 | 01/01/08 |
Bernd Behlert
BRD | Director/Board Member | 65 | 01/09/18 |
Christoph Zindel
BRD | Director/Board Member | 62 | 13/05/22 |
Grit Genster
BRD | Director/Board Member | 51 | 01/05/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 563 237 277 | 411 394 768 ( 73,04 %) | 0 | 73,04 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
FRESENIUS MEDICAL CARE AG 32.17% | 94 380 382 | 32.17% | 3 633 833 468 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Fresenius Securities, Inc.
Fresenius Securities, Inc. Pharmaceuticals: MajorHealth Technology Fresenius Securities, Inc. manufactures and distributes medical products. It provides treatment of kidney failure by hemodialysis and peritoneal dialysis machines. The firm also offers a computer interface module, which performs on-line data collection during dialysis. The company was founded on March 15, 198 and is headquartered in Walnut Creek, CA. |
Pharmaceuticals: Major
|
Medical/Nursing Services
| |
Fresenius Medical Care Holdings, Inc.
Fresenius Medical Care Holdings, Inc. Medical/Nursing ServicesHealth Services Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA. |
Medical/Nursing Services
|
Fresenius Medical Care Deutschland GmbH
Fresenius Medical Care Deutschland GmbH Medical SpecialtiesHealth Technology Part of Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care Deutschland GmbH is a German company that manufactures dialysis machines. The private company is based in Bad Homburg City, Germany. The CEO of the company is Sara Hennicken. |
Medical Specialties
|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. |
Pharmaceuticals: Major
|
Fresenius Kabi South Africa Pty Ltd.
Fresenius Kabi South Africa Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi South Africa Pty Ltd. is a South African pharmaceutical company that manufactures and distributes pharmaceuticals. |
Pharmaceuticals: Major
|
Fresenius ProServe GmbH
Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. |
Hospital/Nursing Management
|
VAMED AG
VAMED AG Miscellaneous Commercial ServicesCommercial Services VAMED AG provides project management and consulting services for hospitals and health care centers. It also offers planning, engineering, contracting, facility management, total operational management, and logistics services. The company was founded in 1982 and is headquartered in Vienna, Austria. |
Miscellaneous Commercial Services
|
Beijing Fresenius Kabi Pharmaceutical Co. Ltd.
Beijing Fresenius Kabi Pharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Part of Fresenius SE & Co. KGaA, Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is a private company that manufactures infusion solutions for volume therapy and standard infusion solutions. Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Fresenius Kabi Pharmaceutical Co. was acquired by Fresenius Kabi AG on April 05, 2005 for $30.21 million. |
Pharmaceuticals: Other
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-3,06% | 16,36 Mrd | |
-14,92% | 84,68 Mrd | |
+13,30% | 81,12 Mrd | |
+10,92% | 29,4 Mrd | |
-12,71% | 16,73 Mrd | |
-2,63% | 14,92 Mrd | |
-3,97% | 11,66 Mrd | |
-1,42% | 11,72 Mrd | |
-31,75% | 11,77 Mrd | |
+27,44% | 11,71 Mrd |
- Borsa valori
- Azioni
- Azione FRE
- Società Fresenius SE & Co. KGaA